Formation of immature neutrophil leucocytes in schizophrenic patients treated with various antipsychotic drugs: Comparisons and predictions

Journal of Psychopharmacology

Volumn 20, Issue 6, 2006, Pages 824-828

  Delieu, J M ^a   Horobin, R W ^b   Duguid, J K ^c  

^a BANGOR UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c WREXHAM MAELOR HOSPITAL   (United Kingdom)

Author keywords

Agranulocytosis; Antipsychotic medication; Atypical; Neutrophil; Nuclear lobe count; Schizophrenia; Typical

Indexed keywords

FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; AGED; AGRANULOCYTOSIS; ARTICLE; CELL ASSAY; CELL MATURATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG EFFECT; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NEUTROPENIA; NEUTROPHIL COUNT; NEUTROPHIL IMMATURITY; PREDICTION; PRIORITY JOURNAL; RANK SUM TEST; RISK; SCHIZOPHRENIA; SHIFT TO THE LEFT; TREATMENT OUTCOME; VARIANCE;

ADULT; AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PREDICTIVE VALUE OF TESTS; SCHIZOPHRENIA;

EID: 33750341527     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106061112     Document Type: Article

References (22)

1. American Psychiatric Association (1997) Guidelines for the treatment of patients with schizophrenia. Am J Psychiatry 154 (Suppl.): 1-63
2. Arneth J (1904) Die Neutrophilen weissen Blutkrperchen bei Infektions-Krankheiten. Fischer, Jena
3. Atkin K, Kendall F, Gould D, Freeman H, Lieberman J, O'Sullivan D (1996) Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 169: 483-488
4. Barnes T R E (ed.) (1993) Antipsychotic Drugs and their Side Effects. Academic Press, London
5. Bhana N, Foster R H, Plosker O, Plosker G L (2001) Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 61: 111-161
6. Cooke W E, Ponder E (1927) The Polynuclear Count. Griffin, London
7. Delieu J M, Badawoud M, Williams M A, Horobin R W, Duguid J K (2001) Antipsychotic drugs result in the formation of immature neutrophil leucocytes in schizophrenic patients. J Psychopharmacol 15: 191-194
8. Dernovsek M Z, Tavcar R (2000) Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone. Int Clin Psychopharmacol 15: 237-238
9. Gerson S L, Meltzer H (1992) Mechanisms of clozapine-induced agranulocytosis. Drug Safety 7 (Suppl. 1): 17-25
10. Hansen T E, Casey D E, Hoffman W F (1997) Antipsychotic intolerance. Schizophr Bull 23: 567-582
11. Jablenski A (1986) Epidemiology of schizophrenia, a European perspective. Schizophr Bull 12: 52-73
12. Johnson D A W, Wright N F (1990) Drug prescribing for schizophrenic outpatients on depot injections. Br J Psychiatry 156: 827-834
13. Kiivet R A, Llerena A, Dahl M L, Rootslane L, Vega J S, Eklundh T, Sjoqvist F (1995) Patterns of drug-treatment of schizophrenic patients in Estonia, Spain and Sweden. Br J Clin Pharmacol 40: 467-476
14. King D J, Wager E (1998) Haematological safety of antipsychotic drugs. J Psychopharmacol. 12: 283-288
15. Mason R P, Fisher V (1992) Possible role of free radical formation in drug-induced agranulocytosis. Drug Safety 7 (Suppl. 1): 45-50
16. Mathy K A, Koepke J A (1973) The clinical usefulness of segmented vs stab neutrophil criteria for differential leucocyte counts. Am J Clin Pathol 61: 947-958
17. Mehta D (ed.) (2005) British National Formulary, number 49. Pharmaceutical Press, London
18. Peacock L, Gerlach J (1996) Antipsychotic-induced side effects related to receptor affinity. In Csernansky J (ed.), Antipsychotics. Springer, Berlin, pp. 360-388
19. Perkins S L (1999) Examination of the blood and bone marrow. In Lee G R, Forester J, Lukens J, Paraskevas F, Greer J P, Rodgers G M (eds), Wintrobe's Clinical Haematology. Williams and Wilkins, Baltimore, MD, pp. 20-21
20. US Food and Drug Administration (2005) Deaths with antipsychotics in elderly patients with behavioral disturbances. FDA Public Health Advisory. Online, available at: www.fda.gov/cder/drug/advisory/ antipsychotics.htm (version current at 30th September 2005
21. Uetrecht J P (1996) Reactive metabolites and agranulocytosis. Eur J Haematol 57 (Suppl.): 83-88
22. Yunis J J, Lieberman J, Yunis E J (1992) Major Histocompatibility Complex associations with clozapine-induced agranulocytosis. Drug safety 7 (Suppl. 1): 1-7